ArticleMolecular diversity2024

Structure-based drug design and characterization of novel pyrazine hydrazinylidene derivatives with a benzenesulfonate scaffold as noncovalent inhibitors of DprE1 tor tuberculosis treatment.

Shivakumar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.